Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 815.46% vs -10.60% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 123.91% vs 4.18% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is -29.80% vs 63.08% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 20.13% vs 91.77% in Mar 2025
Compare Balance Sheet Results of Ajooni Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
34.45
16.61
17.84
107.41%
Share Warrants & Outstandings
Total Reserve
56.74
56.05
0.69
1.23%
Shareholder's Funds
91.19
76.63
14.56
19.00%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.02
0.75
0.27
36.00%
Secured Loans
1.02
0.00
1.02
0.00%
Unsecured Loans
0.00
0.75
-0.75
-100.00%
Deferred Tax Assets / Liabilities
-0.49
-0.00
-0.49
0.00%
Other Long Term Liabilities
0.00
0.07
-0.07
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.29
0.00
0.29
0.00%
Total Non-Current Liabilities
0.82
0.60
0.22
36.67%
Current Liabilities
Trade Payables
8.91
1.25
7.66
612.80%
Other Current Liabilities
2.19
5.48
-3.29
-60.04%
Short Term Borrowings
16.74
0.27
16.47
6,100.00%
Short Term Provisions
0.02
0.00
0.02
0.00%
Total Current Liabilities
27.86
7.00
20.86
298.00%
Total Liabilities
119.87
84.23
35.64
42.31%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
34.07
9.94
24.13
242.76%
Less: Accumulated Depreciation
7.85
2.80
5.05
180.36%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
26.22
7.14
19.08
267.23%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.45
0.68
1.77
260.29%
Long Term Loans & Advances
16.73
21.37
-4.64
-21.71%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
45.40
29.18
16.22
55.59%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
39.46
24.44
15.02
61.46%
Sundry Debtors
17.83
11.81
6.02
50.97%
Cash and Bank
0.42
1.08
-0.66
-61.11%
Other Current Assets
3.03
1.33
1.70
127.82%
Short Term Loans and Advances
13.74
16.40
-2.66
-16.22%
Total Current Assets
74.48
55.05
19.43
35.30%
Net Current Assets (Including Current Investments)
46.61
48.05
-1.44
-3.00%
Total Current Assets Excluding Current Investments
74.48
55.05
19.43
35.30%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
119.87
84.23
35.64
42.31%
Contingent Liabilities
0.00
3.64
-3.64
-100.00%
Total Debt
17.76
0.59
17.17
2,910.17%
Book Value per share (adjusted)
5.29
43.18
-37.89
-87.75%
Annual - Borrowings
Borrowings 17.76 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 815.46% vs -10.60% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 26.22 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 123.91% vs 4.18% in Mar 2025
Annual - Investments
Investments 2.45 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -29.80% vs 63.08% in Mar 2025
Annual - Current Assets
Current Assets 74.48 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 20.13% vs 91.77% in Mar 2025






